| Mr Keith Stauch, | |
|
8610 Brentwood Dr, 1, La Vista, NE 68128-3377 | |
| (402) 331-3232 | |
| Not Available |
| Full Name | Mr Keith Stauch |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 8610 Brentwood Dr, La Vista, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487947115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Keith Stauch, 1301 Galvin Rd S, 208, Bellevue, NE 68005-3712 Ph: (402) 860-3405 | Mr Keith Stauch, 8610 Brentwood Dr, 1, La Vista, NE 68128-3377 Ph: (402) 331-3232 |
News Archive
Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund's "Women of Action" awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.
Dr. Reddy's Laboratories announced today that it has launched ATORVASTATIN CALCIUM TABLETS 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of LIPITOR (atorvastatin calcium) tablets, in the US market on July 17, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for atorvastatin calcium tablets.
Novozymes Biopharma DK A/S, a subsidiary of Novozymes A/S, a world leader in bioinnovation, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
The Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO) and the U.S. medical isotope producer NorthStar have signed a RadioXenon Emissions Pledge.
› Verified 1 days ago
Ted Joseph White, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8563 S 102nd St, La Vista, NE 68128 Phone: 402-651-8670 | |
Jason Mather, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 6949 S 110th St, La Vista, NE 68128 Phone: 531-215-3841 | |
Talia Placzek, Counselor Medicare: Not Enrolled in Medicare Practice Location: 8610 Brentwood Dr, #1, La Vista, NE 68128 Phone: 402-331-3232 | |
Ms. Elizabeth Anne Fichtel, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8610 Brentwood Dr, Suite 1, La Vista, NE 68128 Phone: 402-331-3232 Fax: 402-331-1557 | |
Mrs. Charlotte A Stanton, MS, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8536 Granville Pkwy Apt 836, La Vista, NE 68128 Phone: 402-507-1029 | |
Natasha Hall, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6960 S 110th St, La Vista, NE 68128 Phone: 402-597-4908 | |
Ashlee Maria Houy, LIMHP, LMHC, CPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6949 S 110th St, La Vista, NE 68128 Phone: 402-597-4800 |